Skip to main content
ALK-Abelló logo

ALK-Abelló - Investor Relations & Filings

Listed IPO Jan 2005
Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,240 across all filing types
Latest filing 2026-06-03 Call Transcript
Country DK Denmark
Listing CO ALK · 7 venues

Key figures FY2025

Period ended 2025-12-31 · DKK
Headline annual figures for ALK-Abelló, fiscal year 2025, reported in DKK, with the source filing for each figure.
Total Revenues DKK 6.31B per the Annual Report (ESEF) filed 2026-02-20
Net Income DKK 1.20B per the Annual Report (ESEF) filed 2026-02-20
Total Assets DKK 9.06B per the Annual Report (ESEF) filed 2026-02-20
Total Equity DKK 6.45B per the Annual Report (ESEF) filed 2026-02-20
Cash from Ops DKK 1.82B per the Annual Report (ESEF) filed 2026-02-20

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
TD Cowen 10th Annual Future of the Consumer Conference
Call Transcript Classification · 100% confidence
2026-06-03 English
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions by a person discharging managerial responsibilities (Claus Steensen Sølje) regarding ALK-Abelló A/S shares. It explicitly cites Article 19 of the EU Market Abuse Regulation (MAR), which is the standard regulatory framework for reporting insider/director dealings. Although the title mentions 'managerial staff', the content details the specific acquisition of shares/options by a director, which falls under the 'Director's Dealing' category.
2026-06-01 Danish
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 95% confidence The document is a notification regarding transactions in company shares by managerial staff (insider trading). It explicitly references EU Market Abuse Regulation (MAR) Article 19, which is the standard regulatory framework for reporting director/managerial dealings. Although it mentions an attached PDF, the core purpose of the text is to disclose these specific transactions, which aligns with the 'Director's Dealing' (DIRS) category.
2026-06-01 Danish
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions involving company shares by a member of the Board of Management (Claus Steensen Sølje). It explicitly references Article 19 of the EU Market Abuse Regulation, which governs the reporting of transactions by persons discharging managerial responsibilities (PDMRs). This falls squarely under the definition of 'Director's Dealing' (DIRS).
2026-06-01 English
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 100% confidence The document is a notification regarding transactions in company shares by managerial staff, specifically referencing Article 19 of the EU Market Abuse Regulation. This type of disclosure is standard for 'Director's Dealing' (insider trading) reports. Although it mentions an attachment, the core purpose of the text is to report the specific transaction activity of managerial staff.
2026-06-01 English
AGM 2026
Call Transcript Classification · 100% confidence
2026-05-12 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.